RetinalGenix Technologies Inc. (RTGN)

USD 53.0

(88.0%)

Operating Expenses Summary of RetinalGenix Technologies Inc.

  • RetinalGenix Technologies Inc.'s latest annual operating expenses in 2023 was 2.08 Million USD , up 11.25% from previous year.
  • RetinalGenix Technologies Inc.'s latest quarterly operating expenses in 2024 Q2 was 662.64 Thousand USD , down -69.1% from previous quarter.
  • RetinalGenix Technologies Inc. reported a annual operating expenses of 1.87 Million USD in annual operating expenses 2022, up 25.37% from previous year.
  • RetinalGenix Technologies Inc. reported a annual operating expenses of 1.49 Million USD in annual operating expenses 2021, down -9.11% from previous year.
  • RetinalGenix Technologies Inc. reported a quarterly operating expenses of 662.64 Thousand USD for 2024 Q2, down -69.1% from previous quarter.
  • RetinalGenix Technologies Inc. reported a quarterly operating expenses of 2.08 Million USD for 2023 FY, up 11.25% from previous quarter.

Annual Operating Expenses Chart of RetinalGenix Technologies Inc. (2023 - 2018)

Historical Annual Operating Expenses of RetinalGenix Technologies Inc. (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 2.08 Million USD 11.25%
2022 1.87 Million USD 25.37%
2021 1.49 Million USD -9.11%
2020 1.64 Million USD 104.32%
2019 805.81 Thousand USD 54942.01%
2018 1464.00 USD 0.0%

Peer Operating Expenses Comparison of RetinalGenix Technologies Inc.

Name Operating Expenses Operating Expenses Difference
Acutus Medical, Inc. 11.22 Million USD 81.405%
Biotricity, Inc. 17.18 Million USD 87.855%
Cell MedX Corp. 313.43 Thousand USD -565.874%
Dynatronics Corporation 9.9 Million USD 78.936%
Nemaura Medical Inc. 7.13 Million USD 70.765%
PetVivo Holdings, Inc. 11.36 Million USD 81.629%
Sonendo, Inc. 68.46 Million USD 96.952%
Telesis Bio, Inc. 63.48 Million USD 96.713%
Talis Biomedical Corporation 67.18 Million USD 96.894%
Viveve Medical, Inc. 22.17 Million USD 90.587%